Natera (NASDAQ:NTRA) acquired full enrolment for the RenaCARE (Renasight Clinical Application, Review and Evaluation) study, which is a prospective, multi-center clinical trial to determine...
Technology has the ability to dazzle us with the prospect of a newer, brighter future. It provides curious and interesting options to invigorate, simplify...